INSULIN DESANIC C-TERMINAL LYSINE MODIFICATION
UNII P4V95N8KM3

Substance Identification & Data

This profile provides standardized clinical and technical data for Insulin Desanic C-terminal Lysine Modification, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P4V95N8KM3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
P4V95N8KM3
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INSULIN DESANIC C-TERMINAL LYSINE MODIFICATION
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C69H127N9O26
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
ZXTIXHLSQVEBSJ-YQOHNZFASA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCCCC(O)=O)C(=O)O)(=O)NCCOCCOCC(NCCOCCOCC(NCCOCCOCC(NCCOCCOCC(=O)NCCOCCOCC(NCCOCCOCC(NCCCC[C@H](N)C(=O)O)=O)=O)=O)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Insulin Desanic C-terminal Lysine Modification. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

INSULIN DESANIC C-TERMINAL LYSINE MODIFICATION

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record